Toggle sidebar
定价
登录
Obesity medicine
搜索文档
Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down.
MarketWatch
·
2026-01-05 23:57
公司产品与市场地位 - 诺和诺德公司旗下广受欢迎的肥胖症治疗药物现已推出口服剂型 [1] - 该口服药物成为美国市场首款用于减重的GLP-1片剂 [1]
礼来(US:LLY)
Obesity medicine
Pharmaceuticals
GLP - 1 weight - loss pill
Obesity medicine
Pharmaceuticals
GLP - 1 weight - loss pill